ANIXA BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award
ANIXA BIOSCIENCES, INC. (ANIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award of 0 shares for the 3-month period ending 2013-01-31, per its 10-Q/A filed 2013-03-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward · last filed 2013-03-25
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2013-01-31 was 0.00 shares, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2012-10-31 was 1.84M shares.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2012-01-31 was 950.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 6 month |
|---|---|---|
| 2013-01-31 | 0.00 shares 10-Q/A · filed 2013-03-25 | 1.84M shares derived: sum of 2 quarters · filed 2013-03-25 |
| 2012-10-31 | 1.84M shares 10-K · filed 2013-01-29 | |
| 2012-01-31 | 950.00K shares 10-Q/A · filed 2013-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |